Submitted:
11 September 2024
Posted:
12 September 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Methods
2.1. Setting
2.2. Cameras
2.3. Training Process
2.4. Inclusion/Exclusion Criteria
2.5. Data Collection
2.6. Data Analysis
3. Results
3.1. Patient Participants of the Feasibility Assessment and Pilot of Handheld Cameras
3.2. Image Quality and Diagnosis
3.3. Facilitators
3.4. Barriers
4. Discussion
4.1. Lessons Learned
4.2. Limitations
4.3. Conclusion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye and Vision 2015, 2, 17. [CrossRef]
- Bastos de Carvalho A, Ware SL, Lei F, et al. Implementation and sustainment of a statewide telemedicine diabetic retinopathy screening network for federally designated safety-net clinics. PLOS ONE 2020, 15, e0241767. [CrossRef]
- Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. Arch Ophthalmol 1993, 329, 977-86. [CrossRef]
- Cuadros J, Bresnick G. Can commercially available handheld retinal cameras effectively screen diabetic retinopathy? Journal of Diabetes Sci Technol. 2017, 11, 135-137. [CrossRef]
- American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care 2013, 36, S11–66. [CrossRef]
- Lee DJ, Kumar N, Feuer WJ, et al. Dilated eye examination screening guideline compliance among patients with diabetes without a diabetic retinopathy diagnosis: the role of geographic access. BMJ Open Diabetes Res Care 2014, 2, e000031. [CrossRef]
- Daskivich LP, Vasquez C, Martinez Jr C, et al. Implementation and evaluation of a large-scale teleretinal diabetic retinopathy screening program in the Los Angeles County Department of Health Services. JAMA Intern Med 2017, 177, 642-649. [CrossRef]
- Gibson DM. Estimates of the percentage of US adults with diabetes who could be screened for diabetic retinopathy in primary care settings. JAMA Ophthalmo 2019, 137, 440–444. [CrossRef]
- Tan CH, Kyaw BM, Smith H, et al. Use of smartphones to detect diabetic retinopathy: scoping review and meta-analysis of diagnostic test accuracy studies. J Med Internet Res 2020, 22, e16658. [CrossRef]
- Bruce BB, Newman NJ, Pérez MA, et al. Non-mydriatic ocular fundus photography and telemedicine: past, present, and future. J Neuroophthalmol 2013, 37, 51–7. [CrossRef]
- Jin K, Lu H, Su Z, et al. Telemedicine screening of retinal diseases with a handheld portable non-mydriatic fundus camera. BMC Ophthalmol 2017, 17, 89. [CrossRef]
- Queiroz MS, de Carvalho JX, Bortoto SF, et al. Diabetic retinopathy screening in urban primary care setting with a handheld smartphone-based retinal camera. Acta Diabetol 2020, 57, 1493–1499. [CrossRef]
- Kubin A-M, Wirkkala J, Keskitalo A, et al. Handheld fundus camera performance, image quality and outcomes of diabetic retinopathy grading in a pilot screening study. Acta Ophthalmol 2021, 99, e1415-e1420. [CrossRef]



| Characteristic | Total (n=69) |
|---|---|
| Age | |
| Mean (standard deviation) | 57.0 (11.5) |
| Range (minimum, maximum) | 29, 76 |
| Race/ethnicity | |
| Latino | 58 (84.1%) |
| Asian/Pacific Islander | 5 (7.3%) |
| Black | 1 (1.5%) |
| Other | 5 (7.3%) |
| Gender | |
| Male | 29 (42.0%) |
| Female | 40 (58.0%) |
| A1C | |
| Mean (standard deviation) | 7.6 (1.6) |
| Range (minimum, maximum) | 5.1, 12.7 |
| Diabetes diagnosis | |
| 1 year or less | 14 (20.3%) |
| 2-5 years ago | 22 (31.9%) |
| 6-10 years ago | 16 (23.2%) |
| Over 10 years ago | 17 (24.6%) |
| Diabetic control1 | |
| Excellent | 30 (43.5%) |
| Good | 7 (10.1%) |
| Moderate | 8 (11.6%) |
| Fair | 7 (10.1%) |
| Poor | 17 (24.6%) |
| Hypertension status | |
| Controlled hypertension | 49 (71.0%) |
| Uncontrolled hypertension | 4 (5.8%) |
| No hypertension | 15 (21.7%) |
| Unknown | 1 (1.5%) |
| Last eye exam2 | |
| Never | 15 (21.7%) |
| Within the past 2 years | 38 (55.1%) |
| 2 to 5 years ago | 15 (21.7%) |
| Over 5 years ago | 1 (1.5%) |
| Kappa | Level of agreement | |
|---|---|---|
| Handheld | ||
| Image quality | -0.2857 | Less than slight |
| Diagnosis | -0.1250 | Less than slight |
| Desktop | ||
| Image quality | 0.1346 | Slight |
| Diagnosis | 0.3077 | Fair |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).